Q3 2023 Acasti Pharma Inc Earnings Call Transcript
Good day, and welcome to the Acasti Pharma Reports Third Quarter Fiscal Year 2023 Financial Results and Business Update Call. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to Robert Blum with Lytham Partners. Please go ahead.
All right. Thank you very much, Jason. Welcome to Acasti Pharma's Third Quarter Fiscal 2023 Conference Call. On the call with us this afternoon is Jan D'Alvise, President and CEO; Brian Ford, Chief Financial Officer; Pierre Lemieux, Chief Operating and Scientific Officer; and Acasti Co-Founder and Prashant Kohli, Chief Commercial Officer.
Following management's prepared remarks, there will be a Q&A session. Should any questions remain after the call, please contact me at 602-889-9700. I'd also like to remind everyone that statements on this conference call that are not statements of historical or current facts constitute forward-looking information within the meaning of Canadian securities laws and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |